Skip to main content
Advertisement
Advertisement

CSBR

CSBR logo

Champions Oncology, Inc.

5.02
USD
Sponsored
-0.27
-5.10%
Sep 23, 15:49 UTC -4
Closed
exchange

After-Market

5.03

+0.01
+0.10%

CSBR Earnings Reports

Positive Surprise Ratio

CSBR beat 18 of 34 last estimates.

53%

Next Report

Date of Next Report
Dec 14, 2026
Estimate for Q2 27 (Revenue/ EPS)
$16.70M
/
$0.02
Implied change from Q1 27 (Revenue/ EPS)
+9.66%
/
-166.67%
Implied change from Q2 26 (Revenue/ EPS)
+11.04%
/
--

Champions Oncology, Inc. earnings per share and revenue

On Sep 10, 2026, CSBR reported earnings of -0.03 USD per share (EPS) for Q1 27, missing the estimate of -0.01 USD, resulting in a -194.12% surprise. Revenue reached 15.23 million, compared to an expected 15.35 million, with a -0.76% difference. The market reacted with a +0.09% price change (close before vs. close after earnings).
Looking ahead to Q2 27, -- analysts forecast an EPS of 0.02 USD, with revenue projected to reach 16.70 million USD, implying an decrease of -166.67% EPS, and increase of 9.66% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q1 2027, Champions Oncology, Inc. reported EPS of -$0.03, missing estimates by -194.12%, and revenue of $15.23M, -0.76% below expectations.
The stock price moved up 0.09%, changed from $5.10 before the earnings release to $5.10 the day after.
The next earning report is scheduled for Dec 14, 2026.
Based on -- analysts, Champions Oncology, Inc. is expected to report EPS of $0.02 and revenue of $16.70M for Q2 2027.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement